company background image
IIL logo

Intravenous Infusions GHSE:IIL Stock Report

Last Price

GH₵0.05

Market Cap

GH₵13.7m

7D

0%

1Y

25.0%

Updated

23 Jun, 2024

Data

Company Financials

Intravenous Infusions Plc

GHSE:IIL Stock Report

Market Cap: GH₵13.7m

IIL Stock Overview

A pharmaceutical company, engages in the production and distribution of intravenous infusions and small volume injections for therapeutic purposes in Ghana and the West African sub-region.

IIL fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance3/6
Financial Health4/6
Dividends0/6

Intravenous Infusions Plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Intravenous Infusions
Historical stock prices
Current Share PriceGH₵0.05
52 Week HighGH₵0
52 Week LowGH₵0
Beta0.44
11 Month Change0%
3 Month Changen/a
1 Year Change25.00%
33 Year Change0%
5 Year Change-28.57%
Change since IPO-37.50%

Recent News & Updates

Recent updates

Shareholder Returns

IILGH PharmaceuticalsGH Market
7D0%8.8%0.6%
1Y25.0%23.5%41.5%

Return vs Industry: IIL exceeded the GH Pharmaceuticals industry which returned 23.5% over the past year.

Return vs Market: IIL underperformed the GH Market which returned 41.5% over the past year.

Price Volatility

Is IIL's price volatile compared to industry and market?
IIL volatility
IIL Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement4.0%
Market Average Movement4.0%
10% most volatile stocks in GH Market5.2%
10% least volatile stocks in GH Market1.4%

Stable Share Price: IIL has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine IIL's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1969n/aMoukhtar Soalihuwww.iil.com.gh

Intravenous Infusions Plc, a pharmaceutical company, engages in the production and distribution of intravenous infusions and small volume injections for therapeutic purposes in Ghana and the West African sub-region. The company was incorporated in 1969 and is based in Koforidua, Ghana.

Intravenous Infusions Plc Fundamentals Summary

How do Intravenous Infusions's earnings and revenue compare to its market cap?
IIL fundamental statistics
Market capGH₵13.72m
Earnings (TTM)GH₵5.06m
Revenue (TTM)GH₵31.39m

2.7x

P/E Ratio

0.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IIL income statement (TTM)
RevenueGH₵31.39m
Cost of RevenueGH₵13.06m
Gross ProfitGH₵18.33m
Other ExpensesGH₵13.27m
EarningsGH₵5.06m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.018
Gross Margin58.40%
Net Profit Margin16.12%
Debt/Equity Ratio64.3%

How did IIL perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.